Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierangelo Geppetti

Showing results (141-150 of 227) with videos related to

Pageof 23
Sort By:
Bioorganic & Medicinal Chemistry|February 14, 2012
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammationPier Giovanni Baraldi, Romeo Romagnoli, Giulia Saponaro, et al.
Cells|June 10, 2023
Neuropathic-like Nociception and Spinal Cord Neuroinflammation Are Dependent on the TRPA1 Channel in Multiple Sclerosis Models in MiceDiéssica Padilha Dalenogare, Daniel Souza Monteiro de Araújo, Lorenzo Landini, et al.
Cephalalgia : an International Journal of Headache|November 5, 2024
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort studyAndrea Burgalassi, Marina Romozzi, Giulia Vigani, et al.
Neurology|June 17, 2018
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO studyCristina Tassorelli, Licia Grazzi, Marina de Tommaso, et al.
Basic & Clinical Pharmacology & Toxicology|June 20, 2007
Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanismClaudia Di Serio, Silvia Pellerito, Maria Duarte, et al.
Human Pathology|July 16, 2005
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanomaDaniela Massi, Antonella Naldini, Camilla Ardinghi, et al.
Journal of Cellular and Molecular Medicine|January 14, 2019
TRPA1 mediates the antinociceptive properties of the constituent of Crocus sativus L., safranalSimone Li Puma, Lorenzo Landini, Sergio J Macedo, et al.
Circulation|February 24, 2006
Reduced cardiocirculatory complications with unrestrictive visiting policy in an intensive care unit: results from a pilot, randomized trialStefano Fumagalli, Lorenzo Boncinelli, Antonella Lo Nostro, et al.
Pigment Cell & Melanoma Research|April 17, 2009
Protease-activated receptor-2 downregulation is associated to vitiligo lesionsSilvia Moretti, Romina Nassini, Francesca Prignano, et al.
Pharmacological Research|February 23, 2019
The acyl-glucuronide metabolite of ibuprofen has analgesic and anti-inflammatory effects via the TRPA1 channelFrancesco De Logu, Simone Li Puma, Lorenzo Landini, et al.
Pageof 23

Showing results (141-150 of 227) with videos related to

Sort By:
Pageof 23
Bioorganic & Medicinal Chemistry|February 14, 2012
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammationPier Giovanni Baraldi, Romeo Romagnoli, Giulia Saponaro, et al.
Cells|June 10, 2023
Neuropathic-like Nociception and Spinal Cord Neuroinflammation Are Dependent on the TRPA1 Channel in Multiple Sclerosis Models in MiceDiéssica Padilha Dalenogare, Daniel Souza Monteiro de Araújo, Lorenzo Landini, et al.
Cephalalgia : an International Journal of Headache|November 5, 2024
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort studyAndrea Burgalassi, Marina Romozzi, Giulia Vigani, et al.
Neurology|June 17, 2018
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO studyCristina Tassorelli, Licia Grazzi, Marina de Tommaso, et al.
Basic & Clinical Pharmacology & Toxicology|June 20, 2007
Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanismClaudia Di Serio, Silvia Pellerito, Maria Duarte, et al.
Human Pathology|July 16, 2005
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanomaDaniela Massi, Antonella Naldini, Camilla Ardinghi, et al.
Journal of Cellular and Molecular Medicine|January 14, 2019
TRPA1 mediates the antinociceptive properties of the constituent of Crocus sativus L., safranalSimone Li Puma, Lorenzo Landini, Sergio J Macedo, et al.
Circulation|February 24, 2006
Reduced cardiocirculatory complications with unrestrictive visiting policy in an intensive care unit: results from a pilot, randomized trialStefano Fumagalli, Lorenzo Boncinelli, Antonella Lo Nostro, et al.
Pigment Cell & Melanoma Research|April 17, 2009
Protease-activated receptor-2 downregulation is associated to vitiligo lesionsSilvia Moretti, Romina Nassini, Francesca Prignano, et al.
Pharmacological Research|February 23, 2019
The acyl-glucuronide metabolite of ibuprofen has analgesic and anti-inflammatory effects via the TRPA1 channelFrancesco De Logu, Simone Li Puma, Lorenzo Landini, et al.
Pageof 23